Derfor bør serumlithiumkoncentrationen monitoreres omhyggeligt, hvis lithiumsalte administreres sammen med angiotensin II- receptorantagonister.
Therefore, serum lithium levels should be monitored carefully if lithium salts are to be co- administered with angiotensin II receptor antagonists.